FDA Testing Levels of Carcinogen in Diabetes Drug Metformin
FRIDAY, Dec. 6, 2019 -- Levels of possible cancer-causing chemicals in metformin diabetes medications are under investigation by the U.S. Food and Drug Administration.
During the past year and a half, several types of drugs -- including angiotensin...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Chemistry | Diabetes | Endocrinology | Food and Drug Administration (FDA) | Fortamet | Metformin | Pharmaceuticals